INTERNATIONAL PATENT: AJAX THERAPEUTICS, INC. FILES APPLICATION FOR "MACROCYCLIC HETEROAROMATIC INHIBITORS OF JAK2"

GENEVA, Dec. 2 -- AJAX THERAPEUTICS, INC. (275 Madison Avenue39th FloorNew York, New York 10016) filed a patent application (PCT/US2025/030295) for "MACROCYCLIC HETEROAROMATIC INHIBITORS OF JAK2" on May 21, 2025. With publication no. WO/2025/245175, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MASSE, Craig E. (c/o Ajax Therapeutics, Inc.275 Madison Avenue39th FloorNew York, New York 10016), XU, Jiayi (c/o Schrodinger, L.L.C.1540 Broadway24th FloorNew York, New York 10036), GHANAKOTA, Phani (c/o Schrodinger, L.L.C.1540 ...